about
FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?Nanoparticles: A Neurotoxicological Perspective.Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney.Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications?Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications.Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes.Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway.H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats.Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model.Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis.Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats.Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemiaTelmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathyConcurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathyAngiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic ratsSimultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathyHistone Acetylation Regulates Natriuretic Peptides and Neprilysin Gene Expressions in Diabetic Cardiomyopathy and Nephropathy
P50
Q34488112-946E6907-DCF4-4D63-AA6E-DD632E71C48CQ38571031-4E6B01E8-196D-421E-A088-47A22F3276EBQ38974503-4732E092-C06A-4BA8-B63E-0A50C9AD1B0FQ39248850-42E83CA0-0EF5-44F3-83C6-030AC7F7B291Q41719960-3EE9F0C1-5CDC-4AF3-B868-23C72F3A621DQ48157747-332547AF-004B-4C16-8A9B-3A092842D305Q50990501-759319C6-3278-486B-9754-A118A3BC57BEQ51443083-781D95E0-D661-49D0-A1C3-EADDBDDDA473Q51501737-0AB787ED-EF0E-4591-9C81-72D4426D16F1Q51539245-5F82E35D-5922-4D0F-BC85-26CEE22EDAB1Q51743274-2C60CB2F-D524-4A19-A064-A30ED9BB2B64Q53724709-DC020109-F232-475A-97C8-55F05A06F22BQ53816344-62A561AB-6159-46E9-9BB7-34071B525954Q87141519-DB7CF4B3-872E-4902-B9C9-7BF9781012A6Q91298413-3B2A4980-BC2B-4317-9748-F8A6A354D1C8Q91623950-F0A1D115-30EF-4467-845D-683A1892B2FEQ93012961-FA4C1BAE-369F-4733-86DB-D4A170FA836DQ93014560-7BE6D9BC-AA89-4223-810A-A85A993FF3F4Q93347869-6A28C724-CD34-4471-8CB4-3E4554A5D4D7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Vajir Malek
@en
Vajir Malek
@nl
type
label
Vajir Malek
@en
Vajir Malek
@nl
prefLabel
Vajir Malek
@en
Vajir Malek
@nl
P31
P496
0000-0003-3680-058X